AI Cloud momentum and Apollo Go expansion power BIDU's 42.3% run, yet intensifying AI battles call for a patient hold.

Agriculture stocks largely rallied sharply to the upside while metal manufacturers like MP Materials (MP) sold off. George Tsilis talks about how tariffs generated big moves in these stocks and explains the retail and institutional investments shaking earth-tethered stocks.

SAN FRANCISCO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract. The suit, Norrman v.

FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, had previously announced that it had filed an application to appeal the delisting notification previously received from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) and request a hearing before a Nasdaq Hearings Panel to review the Staff's delisting determination.

FOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, had previously announced that it had filed an application to appeal the delisting notification previously received from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) and request a hearing before a Nasdaq Hearings Panel to review the Staff's delisting determination.

Docusign's deep ties with Microsoft and Salesforce, rising cash flow and steady growth outlook signal a potential rebound ahead.

VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.

APH's robust order growth, acquisitions and expanding interconnect portfolio are fueling strong momentum across key end markets.

indie Semiconductor (INDI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

PHILADELPHIA , Oct. 15, 2025 /PRNewswire/ -- Berger Montague PC , national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Gold prices have more than doubled since 2020, creating a favorable environment for producers like B2Gold. B2Gold's Goose Mine will drive production growth from 120K-150K ounces in 2025 to ~300K ounces annually by 2026-2027. Fekola Regional project adds ~180K ounces annually starting in 2026, while Gramalote could contribute 177K ounces post-permitting.

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good covered call trade candidates due to the liquidity and lucrativeness of the option premiums against these equities. Stocks had their biggest decline last Friday since the first half of April due to escalating trade tensions between the U.S. and China.

Cerence (CRNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Berkshire Hathaway and Arch Capital stand out as insurance titans, each with unique strengths driving growth, profitability and resilience through 2025.

AI-driven Search momentum, easing regulatory headwinds and strong stock gains make GOOGL a compelling long-term hold despite valuation concerns.

Fintech giant Affirm (AFRM) is clinging to its quarter-to-date breakeven level as it attempts to claw its way higher, last seen up 0.5% to trade at $73.28. While the round $70 level has been supportive in recent weeks, AFRM has been unable to break above the $80 ceiling.

Agora integrates its Conversational AI Engine with Exotel's AgentStream across PSTN and IP Channels to enable plug-and-play AI voice bots. SANTA CLARA, Calif.

MUNCIE, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- First Merchants Corporation (NASDAQ: FRME) has declared a quarterly cash dividend of $46.88 per share on its 7.50% Non-Cumulative Perpetual Preferred Stock Series A, represented by depositary shares (NASDAQ: FRMEP) each representing a 1/100th interest in a share of the Series A preferred stock. Holders of depositary shares will receive $0.4688 per depositary share. The dividend will be payable on November 14, 2025, to stockholders of record on October 31, 2025.

AT&T has doubled its stock price since 2023, driven by network modernization and a renewed focus on core telecom operations. T is aggressively expanding its 5G and fiber networks, aided by strategic spectrum acquisitions and favorable tax incentives from recent legislation. Despite a saturated market and substantial debt, T's strong free cash flow, robust dividend yield, and infrastructure moat support its investment case.

SAN FRANCISCO--(BUSINESS WIRE)--A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report. The firm urges investors in LifeMD who suffered significant losses to submi.